Cite

HARVARD Citation

    Saeki, H. et al. (2022). An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in Japan. Journal of dermatological treatment. pp. 229-239. [Online]. 
  
Back to record